SAN DIEGO, Nov. 26 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a provider of intravascular ultrasound (IVUS) and functional measurement (FM) products designed to enhance the diagnosis and treatment of vascular and structural heart disease, said today that it will be participating in the Piper Jaffray 19th Annual Health Care Conference on Wednesday, November 28.
The presentation by Scott Huennekens, president and chief executive officer, will be begin at 3 p.m., Eastern Standard Time (12 p.m., Pacific Standard Time).
The presentation will be available through http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=VOLC&item_id=16890 74 or via the company's website at http://www.volcanocorp.com.
Volcano Corporation (Nasdaq: VOLC) offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart diseases and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly in virtually any modern cath lab. Volcano IVUS offers unique features, including both single-use phased array and rotational IVUS imaging catheters, and advanced functionality options, such as VH(TM) IVUS tissue characterization and ChromaFlo(R). Volcano also provides functional measurement (FM) consoles and single-use pressure and flow guide wires. Currently, more than 2,900 Volcano IVUS and FM systems are installed worldwide, with approximately half of its revenues coming from outside the United States. For more information, visit the company's website at http://www.volcanocorp.com.
|SOURCE Volcano Corporation|
Copyright©2007 PR Newswire.
All rights reserved